[1] Hamilton SR, Aaltonen LA.世界卫生组织肿瘤分类及诊断标准系列-消化系统肿瘤病理学和遗传学[M]. (虞姬耀译) .北京:人民卫生出版社, 2006∶254.
|
[2]Sternberg SS.诊断外科病理学[M]. (回允中译) .第3版.北京:北京大学医学出版社, 2003∶1649.
|
[3]Zhu H, Chen XP, Zhang WG, et al.Expression and significance of new inhibitor of apoptosis protein survivin in hepatocellularcarcinoma[J].World J Gastroenterol, 2005, 11 (25) ∶3855-3859.
|
[4]Li Fz.Survivin study:what is the next wave-[J].Cell physiol, 2003, 1997 (1) ∶8-29.
|
[5]Akhtar M, Gallagher L, Rohan S.Survivin:Role in diagnosis, prog-nosis, and treatment of bladder cancer[J].Adv Anat Pathol, 2006, 13 (3) ∶122-126.
|
[6]Zaffaroni N, Pennati M, Daidone MG.Survivin as a target for new anticancer intervention[J].J Cell Mol Med, 2005, 9 (2) ∶360-372.
|
[7]Cohen C, Lohmann CM, Cotsonis G, et al.Survivin expression in car-cinoma:Correlation with apoptotic marker and prognosis[J].Mod Pathol, 2003, 16 (6) ∶574-583.
|
[8]Kazuhiro K, Ryuichiro D, Masayuki K, et al.Survivin expression is a prognostic marker in pancreatic cancer patients[J].Surgery, 2004, 13 (2) ∶443-448.
|
[9]Crossman DMC, Niff JM, Li F.Expression of the apoptosis inhibitor survivin, in nonmelanoma skin cancer and gene targeting in a kerati-noyte cell line[J].Lab Invest, 1999, 79 (9) ∶121-126.
|